lifestyle.onlygolfnews.com

Author: Lexaria Bioscience Corp.

Lexaria Awarded Six Additional Patents

January 22, 2026
Lexaria Releases Annual Letter from the CEO

January 12, 2026
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

December 30, 2025
Primary Endpoint Successfully Achieved in Lexaria’s Phase 1b Study GLP-1-H24-4

December 23, 2025
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

December 18, 2025
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

December 15, 2025